Discover 2,528 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,528
Active & Responsive
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
for
X-linked Retinoschisis
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Atsena Therapeutics Inc.
Sex: All
Age: 6+
Code: NCT05878860
Phase3, Recruiting
Active & Responsive
The Progressive Supranuclear Palsy Clinical Trial Platform
for
Progressive Supranuclear Palsy(PSP)
Location: San Francisco CA
Sponsor: Adam Boxer
Sex: All
Age: 41 - 70+
Code: NCT07173803
Phase2, Recruiting
Active & Responsive
Neonatal White Matter Injury Trial (WRAP)
for
White Matter Injury, Brain Injury, Fetus and Neonate,
Location: San Francisco CA
Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D.
Sex: All
Age: 0
Code: NCT07688746
Phase1, Recruiting
Active & Responsive
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD
Sex: All
Age: 18+
Code: NCT07043608
Phase2, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: San Francisco CA, Orange CA, Salt Lake City UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Salt Lake City UT, Seattle WA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase2, Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase1, Recruiting
Active & Responsive
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
for
Cirrhosis, Frailty, Sarcopenia
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07029243
Recruiting
Active & Responsive
PVI Alone Versus PVI Plus PWI and SVCI With PFA
for
Persistent Atrial Fibrillation
Location: San Francisco CA
Sponsor: Edward Gerstenfeld, MD
Sex: All
Age: 18+
Code: NCT07405359
Recruiting
Active & Responsive
A Gaucher Disease Gene Therapy Trial With FLT201
for
Gaucher Disease Type 1
Location: San Francisco CA, Los Angeles CA, Aurora CO, Calgary,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: San Francisco CA, Eugene OR, La Jolla CA, Portland OR,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase2, Recruiting
Active & Responsive
Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department
for
Opioid Use Disorder, Social Determinants of Health (SDOH)
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06872190
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies